Exact Mass: 408.2512

Exact Mass Matches: 408.2512

Found 500 metabolites which its exact mass value is equals to given mass value 408.2512, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cholic acid

(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


Cholic acid is a bile acid that is 5beta-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12. It has a role as a human metabolite and a mouse metabolite. It is a bile acid, a C24-steroid, a 3alpha-hydroxy steroid, a 7alpha-hydroxy steroid, a 12alpha-hydroxy steroid and a trihydroxy-5beta-cholanic acid. It is a conjugate acid of a cholate. Cholic acid is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Cholic acid is a Bile Acid. Cholic acid is a naturally occurring bile acid that is used to treat patients with genetic deficiencies in the synthesis of bile acids. When given in high doses, cholic acid replacement therapy has been linked to minor elevations in serum aminotransferase levels, but it has not been linked to instances of clinically apparent acute liver injury with jaundice. Cholic acid is a natural product found in Caenorhabditis elegans, Bufo bufo, and Homo sapiens with data available. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (A3407, A3408, A3409, A3410). A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. See also: Cholic acid; ferrous gluconate; honey (component of). Cholic acid is a major primary bile acid produced in the liver and is usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, and depends only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). When present in sufficiently high levels, cholic acid can act as a hepatotoxin and a metabotoxin. A hepatotoxin causes damage to the liver or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Among the primary bile acids, cholic acid is considered to be the least hepatotoxic while deoxycholic acid is the most hepatoxic (PMID: 1641875). The liver toxicity of bile acids appears to be due to their ability to peroxidate lipids and to lyse liver cells. Chronically high levels of cholic acid are associated with familial hypercholanemia. In hypercholanemia, bile acids, including cholic acid, are elevated in the blood. This disease causes liver damage, extensive itching, poor fat absorption, and can lead to rickets due to lack of calcium in bones. The deficiency of normal bile acids in the intestines results in a deficiency of vitamin K, which also adversely affects clotting of the blood. The bile acid ursodiol (ursodeoxycholic acid) can improve symptoms associated with familial hypercholanemia. Cholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=81-25-4 (retrieved 2024-06-29) (CAS RN: 81-25-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

α-Muricholic acid

(4R)-4-[(1S,2R,5R,7R,8S,9S,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


alpha-Muricholic acid is a hydroxylated bile acid present in normal human urine (PMID: 1629271), and in free glycine-conjugated, taurine-conjugated, and sulfated forms in human feces (PMID: 3667743). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). a-Muricholic acid is an hydroxylated bile acid present in normal human urine (PMID 1629271), and free, glycine-conjugated, taurine-conjugated and sulphated forms in human feces (PMID 3667743). α-Muricholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=2393-58-0 (retrieved 2024-06-29) (CAS RN: 2393-58-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

1-palmitoyl-dihydroxyacetone-phosphate

Hexadecanoic acid 2-oxo-3-(phosphonooxy)propyl ester

C19H37O7P (408.2277)


1-palmitoyl-dihydroxyacetone-phosphate is also known as Palmitoyl glycerone phosphate or Hexadecanoate 2-oxo-3-(phosphonooxy)propyl ester. 1-palmitoyl-dihydroxyacetone-phosphate is considered to be practically insoluble (in water) and acidic. 1-palmitoyl-dihydroxyacetone-phosphate is an other glycerophospholipid lipid molecule

   

Asebotoxin II

Asebotoxin II

C23H36O6 (408.2512)


   
   

1b,3a,7a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,3R,5S,7S,9R,10S,11S,14R,15R)-3,5,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


1b,3a,7a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. [HMDB] D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

Phocaecholic acid

beta-Phocaecholate; beta-Phocaecholic acid; (23R)-Hydroxychenodeoxycholate

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts

   

Bitocholic acid

(23R)-3α,12α,23-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


Bitocholic acid is a bile acid, which is a type of steroid acid found in the bile of mammals. It is synthesized from cholesterol in the liver and plays a crucial role in the digestion and absorption of lipid-soluble vitamins and the metabolism of lipids and cholesterol. Bitocholic acid is a specific type of bile acid, although it is not commonly found in nature and may be produced under certain conditions or through chemical synthesis.

   

Avicholic acid

3α,7α,16α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3, 7 and 16 (the 3alpha,7alpha,16alpha stereoisomer). It is a major constituent of the bile of several avian species. Avicholic acid is a bile acid, which is a type of steroid acid found in the bile of mammals. It is synthesized from cholesterol in the liver and plays a crucial role in the digestion and absorption of lipid-soluble vitamins and the metabolism of lipids and cholesterol. Avicholic acid is a specific type of bile acid, although it is not commonly found in nature and may be produced under certain conditions or through chemical synthesis.

   

Haemulcholic acid

Haemulcholate; Hemulcholic acid; 3alpha,7alpha,22-Trihydroxy-5beta-cholan-24-oic acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

Cygnocholic acid

Cygnocholate; Cygnocholic acid; 3alpha,7alpha,15alpha-Trihydroxy-5beta-cholan-24-oic acid

C24H40O5 (408.2876)


   

3a,6a,7b-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2R,5R,7R,8R,9R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,6a,7b-Trihydroxy-5b-cholanoic acid is an unusual trihydroxy bile acid found in the urine of healthy humans, mainly in newborns (PMID 3769218). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 6, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 3a,6a,7b-Trihydroxy-5b-cholanoic acid is an unusual trihydroxy bile acid found in the urine of healthy humans, mainly in newborns (PMID 3769218). D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

β-Muricholic acid

(4R)-4-[(1S,2R,5R,7R,8S,9R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,6b,7b-Trihydroxy-5b-cholanoic acid, also known as beta-muricholic acid, is a bile acid. 3a,6b,7b-Trihydroxy-5b-cholanoic acid belongs to the class of compounds known muricholic acids in which the hydroxy groups at positions 6 and 7 both have a beta configuration. It is also classified as a 6beta-hydroxy steroid, a 7beta-hydroxy steroid, a steroid acid and a bile acid. Muricholic acids are a group of bile acids that are particularly abundant in mice, which gives them their name. Muricholic acids are also found at low concentrations in other mammalian species, including humans (PMID: 12543708). Muricholic acids differ from the primary bile acids found in humans (which are cholic acid and chenodeoxycholic acid) by having a hydroxyl group in the beta-conformation at the 6-position. The orientation of the hydroxyl group at the 7 position defines alpha- or beta-muricholic acid. Muricholic acids are detectable at low concentrations in human urine (PMIDL 1629271). The enzyme responsible for the 6-hydroxylation reactions forming muricholates in rodents is the cytochrome P450 Cyp2c70. This produces alpha-muricholic acid from chenodeoxycholic acid, and beta-muricholic acid from ursodeoxycholic acid. Bile acids, such as muricholic acid, are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 6, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 3a,6b,7b-Trihydroxy-5b-cholanoic acid is a bile acid found in urine exhibiting a complex modification pattern, including free, glyco- and sulfoconjugated forms (PMID 3834660). β-Muricholic acid is a potent and orally active biliary cholesterol-desaturating agent. β-Muricholic acid prevents cholesterol gallstones. β-Muricholic acid inhibits lipid accumulation. β-Muricholic acid has the potential for the research of nonalcoholic fatty liver disease (NAFLD)[1][2].

   

Allocholic acid

(4R)-4-[(1S,2S,5R,7R,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


Allocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). [Analytical] Sample of 1 micorL methanol solution was flow injected. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 271 Allocholic acid is a typically fetal bile acid found in vertebrates and reappears during liver regeneration and carcinogenesis, besides it is also a conjugate acid of allocholate and an isomer of cholic acid. Allocholic acid is a potent and specific stimulant of the adult olfactory system, it has a role as a marine metabolite, a rat metabolite and a human metabolite[1][2][3].

   

Ursocholic acid

(4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


Ursocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Ursocholic acid is the 7 beta-hydroxyepimer of cholic acid. It induces a reduction of bile cholesterol saturation. A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Ursocholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=2955-27-3 (retrieved 2024-07-16) (CAS RN: 2955-27-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Ursocholic acid, a bile acid found predominantly in bile of mammals, is transformed into deoxycholic acid by the intestinal microflora in mice. Ursodeoxycholic acid is an inhibitor of 7α-hydroxysteroid dehydrogenase and hepatocyte nuclear factor 1α[1].

   

Hyocholic Acid

3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid in which the three hydroxy substituents are located at the 3alpha-, 6alpha- and 7alpha-positions. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 267

   

Bile acid

Bile acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts

   

3alpha,7alpha,16alpha-trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7alpha,16alpha-trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,7alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

(4S)-4-[(3R,5S,7R,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

Cholic Acid

3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid

C24H40O5 (408.2876)


Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

3alpha,7alpha,12beta-Trihydroxy-5beta-cholanoic acid

(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16R)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3alpha,7alpha,12beta-Trihydroxy-5beta-cholanoic acid, also known as lagocholic acid, is a bile acid. Bile acids with beta-hydroxyl and carbonyl groups at the C-3,7, and/or 12 positions are bile acids usually found in the urine of healthy humans (PMID: 8743575). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy > A05AA - Bile acids and derivatives C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Same as: D10699 Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

1b,3a,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(2S,3R,5S,15R,16S)-3,5,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


1b,3a,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues.

   

Heterophylol

6a,7,12,12a-tetrahydro-9,11-Dimethoxy-6,6-dimethyl-8-(3-methyl-2-butenyl)-6H-benzo[b]naphtho[2,3-D]pyran-3-ol, 9ci

C26H32O4 (408.23)


Heterophylol is found in fruits. Heterophylol is a constituent of the root bark of Artocarpus heterophyllus (jackfruit). Constituent of the root bark of Artocarpus heterophyllus (jackfruit). Heterophylol is found in fruits.

   

Sinapoylspermine

(2Z)-N-(3-aminopropyl)-N-{4-[(3-aminopropyl)amino]butyl}-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enamide

C21H36N4O4 (408.2736)


Sinapoylspermine is found in brassicas. Sinapoylspermine is an alkaloid from Brassica oleracea var. botrytis (cauliflower). Alkaloid from Brassica oleracea variety botrytis (cauliflower). Sinapoylspermine is found in brassicas.

   

6a,12a-Dihydroxylithocholic acid

(4R)-4-[(1S,2R,5R,8S,10R,11S,14R,15R,16S)-5,8,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


6a,12a-Dihydroxylithocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 6a,12a-Dihydroxylithocholic acid has been identified in the urine of patients with cholestasis (PMID 7444367). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

cis-Methylbixin

1,20-Dimethyl (4Z,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioic acid

C26H32O4 (408.23)


cis-Methylbixin is a constituent of Bixa orellana (annatto). Constituent of Bixa orellana (annatto)

   

Apo-10'-violaxanthal

(2Z,4Z,6E,8E,10E,12Z,14E)-15-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenal

C27H36O3 (408.2664)


Apo-10-violaxanthal is found in citrus. Apo-10-violaxanthal is isolated from Valencia orange peels. Isolated from Valencia orange peels. Apo-10-violaxanthal is found in sweet orange and citrus.

   

3a,4b,7a-Trihydroxy-5b-cholanoic acid

(4S)-4-[(1S,2R,5R,6R,7S,9R,10S,11S,15R)-5,6,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,4b,7a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3a,4b,7a-Trihydroxy-5b-cholanoic acid accounts for 5-15\\% of the total biliary bile acids in early gestation, has been identified in the feces from healthy newborn infants many days after birth, indicating a hepatic origin for C-4 hydroxylation of bile acids. PMID 2794778). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3a,4b,7a-Trihydroxy-5b-cholanoic acid accounts for 5-15\\% of the total biliary bile acids in early gestation, has been identified in the feces from healthy newborn infants many days after birth, indicating a hepatic origin for C-4 hydroxylation of bile acids. PMID 2794778) [HMDB]

   

3a,4b,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-5-Hydroxy-2,15-dimethyl-16-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoate

C24H40O5 (408.2876)


3a,4b,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

1,3,12-Trihydroxycholan-24-oic acid

(4R)-4-[(1S,2S,10S,11S,14R,15R)-3,5,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


1,3,12-Trihydroxycholan-24-oic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135).

   

3b,7a,12a-Trihydroxy-5a-Cholanoic acid

(4R)-4-[(1S,2S,5S,7R,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7a,12a-Trihydroxy-5a-Cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3b,7a,12a-Trihydroxy-5a-Cholanoic acid has been identified in the bile, plasma and urine of patients with delta 4-3-oxosteroid 5 beta-reductase deficiency with neonatal hepatitis, an inborn error in bile acid synthesis. (PMID 3198770). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3b,7a,12a-Trihydroxy-5a-Cholanoic acid has been identified in the bile, plasma and urine of patients with delta 4-3-oxosteroid 5 beta-reductase deficiency with neonatal hepatitis, an inborn error in bile acid synthesis. (PMID 3198770) [HMDB]

   

3a,7b,12b-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R,16R)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,7b,12b-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

3b,7b,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5S,7S,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7b,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 3b,7b,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

2b,3a,7a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,4S,5S,7R,9R,10R,11S,14R,15R)-4,5,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


2b,3a,7a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

3b,7a,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5S,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7a,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135).

   

3b,7b,12a-Trihydroxy-5a-Cholanoic acid

(4R)-4-[(1S,2S,5S,7R,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7b,12a-Trihydroxy-5a-Cholanoic acid is a bile acid present in the urine of healthy humans, predominantly found in the glycine conjugate fraction (PMID 864325). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. [HMDB] 3b,7b,12a-Trihydroxy-5a-Cholanoic acid is a bile acid present in the urine of healthy humans, predominantly found in the glycine conjugate fraction (PMID 864325). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

3a,7b,12a-Trihydroxy-5a-Cholanoic acid

(4R)-4-[(1S,2S,5R,7R,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,7b,12a-Trihydroxy-5a-Cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135).

   

Hyocholate

(4R)-4-[(1S,2R,5R,7R,8R,9S,10S,11S,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


Hyocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

Muricholic acid

(4R)-4-[(1S,2R,5R,7R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


A bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

trans-Methylbixin

1,20-dimethyl (2E,4E,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

C26H32O4 (408.23)


trans-Methylbixin is a constituent of Bixa orellana (annatto). Constituent of Bixa orellana (annatto)

   

1-(9Z-hexadecenoyl)-glycero-3-phosphate

[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropoxy]phosphonic acid

C19H37O7P (408.2277)


1-(9Z-hexadecenoyl)-glycero-3-phosphate is also known as LPA(16:1(9Z)/0:0). 1-(9Z-hexadecenoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(9Z-hexadecenoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule

   

3,6,7-Trihydroxycholan-24-oic acid

3,6,7-Trihydroxycholan-24-oic acid

C24H40O5 (408.2876)


   

Allocholate

4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanoic acid

C24H40O5 (408.2876)


Allocholic acid is a typically fetal bile acid found in vertebrates and reappears during liver regeneration and carcinogenesis, besides it is also a conjugate acid of allocholate and an isomer of cholic acid. Allocholic acid is a potent and specific stimulant of the adult olfactory system, it has a role as a marine metabolite, a rat metabolite and a human metabolite[1][2][3].

   

Butaprost

Methyl 7-{3-hydroxy-2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-en-1-yl]-5-oxocyclopentyl}heptanoic acid

C24H40O5 (408.2876)


   

Lofentanilum

methyl 3-methyl-1-(2-phenylethyl)-4-(N-phenylpropanamido)piperidine-4-carboxylate

C25H32N2O3 (408.2413)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

QUINGESTANOL ACETATE

(3-cyclopentyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl) acetate

C27H36O3 (408.2664)


   

MG(PGJ2/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

C23H36O6 (408.2512)


MG(PGJ2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/PGJ2/0:0)

1,3-Dihydroxypropan-2-yl (5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

C23H36O6 (408.2512)


MG(0:0/PGJ2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

[8]-Gingerdiol

3-(Acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)dodecan-5-yl acetic acid

C23H36O6 (408.2512)


[8]-gingerdiol is a member of the class of compounds known as fatty alcohol esters. Fatty alcohol esters are ester derivatives of a fatty alcohol. [8]-gingerdiol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). [8]-gingerdiol can be found in ginger, which makes [8]-gingerdiol a potential biomarker for the consumption of this food product.

   

(9Z,9'Z)-Methylbixin

1,20-dimethyl (2E,4Z,6E,8E,10E,12E,14E,16Z,18E)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

C26H32O4 (408.23)


Constituent of Bixa orellana (annatto).

   

Leoheteronone C

Leoheteronone C

C23H36O6 (408.2512)


   

Sargachromanol P

Sargachromanol P

C27H36O3 (408.2664)


   

Tenuifolin A (isoflavan)

(3R)-7,4-Dihydroxy-2-methoxy-5-(1,1-dimethyl-2-propenyl)-8-prenyloxyisoflavan

C26H32O4 (408.23)


   

Aculeatol D

Aculeatol D

C24H40O5 (408.2876)


   

Tupuseleiamide B

Tupuseleiamide B

C21H32N2O6 (408.226)


   

Umbellacin F

Umbellacin F

C23H36O6 (408.2512)


   

Tasnemoxide A

Tasnemoxide A

C24H40O5 (408.2876)


   

iso-Spiculoic acid A

(+)-iso-Spiculoic acid A

C27H36O3 (408.2664)


   

Dendronpholide D

Dendronpholide D

C23H36O6 (408.2512)


   

Tasnemoxide B

Tasnemoxide B

C24H40O5 (408.2876)


   
   

Helogynic acid

Helogynic acid

C23H36O6 (408.2512)


   

Tupuseleiamide A

Tupuseleiamide A

C21H32N2O6 (408.226)


   

Xenimanadin B

Xenimanadin B

C23H36O6 (408.2512)


   

12,28-Oxaircinal A

12,28-Oxaircinal A

C26H36N2O2 (408.2777)


   

adunctin A

adunctin A

C26H32O4 (408.23)


   
   

2beta,15-Dihydroxy-ent-7-labdene-2-O-methylmalonate

2beta,15-Dihydroxy-ent-7-labdene-2-O-methylmalonate

C24H40O5 (408.2876)


   

[8]-Gingerdiol

[8]-Gingerdiol

C23H36O6 (408.2512)


   

Epimuqubilin B

Epimuqubilin B

C24H40O5 (408.2876)


   

Sarcrassin C

Sarcrassin C

C23H36O6 (408.2512)


   

Anisodorin 5

Anisodorin 5

C24H40O5 (408.2876)


   

cis-Methylbixin

1,20-Dimethyl (4Z,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioic acid

C26H32O4 (408.23)


cis-Methylbixin is a constituent of Bixa orellana (annatto). Constituent of Bixa orellana (annatto)

   

Cholic Acid

sodium cholate hydrate

C24H40O5 (408.2876)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; BHQCQFFYRZLCQQ-OELDTZBJSA-N_STSL_0091_Cholic acid_8000fmol_180416_S2_LC02_MS02_85; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.368 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.366 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.369 Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

Methyllinderatin

2,6-Dihydroxy-3- (6-isopropyl-3-methylcyclohex-2-enyl) -4-methoxydihydrochalcone

C26H32O4 (408.23)


   

MCULE-3591387207

MCULE-3591387207

C24H40O5 (408.2876)


   

CHEMBL3781424

CHEMBL3781424

C26H32O4 (408.23)


   

SCHEMBL10685062

SCHEMBL10685062

C23H36O6 (408.2512)


   

alpha-muricholic acid

3a,6b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids [Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   
   

flexibilisin A|granosolide D

flexibilisin A|granosolide D

C23H36O6 (408.2512)


   

Peroxyacarnoic acid C

Peroxyacarnoic acid C

C23H36O6 (408.2512)


   

Nimbocinol

Nimbocinol

C26H32O4 (408.23)


A tetracyclic triterpenoid that is 4,4,8-trimethylandrosta-1,14-diene substituted by a oxo groups at positions 3 and 16, a hydroxy group at position 7 and a furan-3-yl group at position 17. It has been isolated from Azadirachta indica.

   

antiarotoxinin A

antiarotoxinin A

C23H36O6 (408.2512)


   

8-hydroxy-13E-labden-15-yl-methyl malonic acid diester

8-hydroxy-13E-labden-15-yl-methyl malonic acid diester

C24H40O5 (408.2876)


   

artochamin I

artochamin I

C26H32O4 (408.23)


   

(rel 5S,6R,8R,9R,10S,13S,16S)-6-acetoxy-9,13-epoxy-16-methoxy-labdan-15,16-olide

(rel 5S,6R,8R,9R,10S,13S,16S)-6-acetoxy-9,13-epoxy-16-methoxy-labdan-15,16-olide

C23H36O6 (408.2512)


   
   

1-[3-(2-dimethylaminoethyl)-5-hydroxy-1h-4-indolyl]-3-hydroxy-3-(2-methylaminoethyl)-2-indolinone

1-[3-(2-dimethylaminoethyl)-5-hydroxy-1h-4-indolyl]-3-hydroxy-3-(2-methylaminoethyl)-2-indolinone

C23H28N4O3 (408.2161)


   
   

atomarianone A

atomarianone A

C27H36O3 (408.2664)


   

negombatoperoxide A

negombatoperoxide A

C24H40O5 (408.2876)


   

Kazinol N

Kazinol N

C26H32O4 (408.23)


   

spiculoic acid A

spiculoic acid A

C27H36O3 (408.2664)


A carbobicyclic compound that is 2,3,3a,4,5,7a-hexahydro-1H-indene substituted by ethyl groups at positions 3, 4, 5 and 7, a methyl group at position 1, an oxo group at position 2, a 2-phenylethenyl group at position 5 and a carboxy group at position 4 (the 1R,3R,3aS,4S,5R,7aS stereoisomer). Isolated from Plakortis angulospiculatus, it exhibits cytotoxicity against human breast cancer MCF-7 cells.

   

hirsutalin E

hirsutalin E

C24H40O5 (408.2876)


A natural product found in Cladiella hirsuta.

   

chromarol E

chromarol E

C27H36O3 (408.2664)


   

(3S,5S,8R,9R,10S,13S,16S)-3-acetoxy-9,13-epoxy-16-methoxylabdan-15,16-olide|negundoin D

(3S,5S,8R,9R,10S,13S,16S)-3-acetoxy-9,13-epoxy-16-methoxylabdan-15,16-olide|negundoin D

C23H36O6 (408.2512)


   

(3alpha,5beta,12alpha,16alpha)-3,12,16-Trihydroxycholan-24-oic acid

(3alpha,5beta,12alpha,16alpha)-3,12,16-Trihydroxycholan-24-oic acid

C24H40O5 (408.2876)


   

rhopaloic acid G

rhopaloic acid G

C24H40O5 (408.2876)


   

Australifungin

Australifungin

C23H36O6 (408.2512)


A carbobicyclic compound that is 4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one substituted by hydroxy groups at positions 2, 5 and 8, a (2Z)-3-hydroxyprop-2-enoyl group at position 4, methyl groups at positions 4 and 7 and a 2R-octan-2-yl group at position 3 (the 4S,4aR,5S,7R,8R,8aS stereoisomer). It is isolated from the fermentation extracts of Sporormiella australis and exhibits antifungal activity by interfering with the fungal lipid metabolism.

   

18-methylmalonyltrinerdiol

18-methylmalonyltrinerdiol

C24H40O5 (408.2876)


   
   

(rel-5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-16-methoxy-13(14)-labden-15,16-olide|viteagnusin H

(rel-5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-16-methoxy-13(14)-labden-15,16-olide|viteagnusin H

C23H36O6 (408.2512)


   

15,16-diacetyl-trinertriol

15,16-diacetyl-trinertriol

C24H40O5 (408.2876)


   
   

2-(2-acetoxytridecyl)-6-hydroxy-4-methoxybenzoic acid

2-(2-acetoxytridecyl)-6-hydroxy-4-methoxybenzoic acid

C23H36O6 (408.2512)


   

Gerronemin E

Gerronemin E

C27H36O3 (408.2664)


   

2beta,3alpha,15-Trihydroxy-ent-labd-7-ene 2,15-diacetate

2beta,3alpha,15-Trihydroxy-ent-labd-7-ene 2,15-diacetate

C24H40O5 (408.2876)


   

12-Deoxy,2-Ac,4-Me ether-(2R,12S)-6-(2,12-Dihydroxytridecyl)-2,4-dihydroxybenzoic acid

12-Deoxy,2-Ac,4-Me ether-(2R,12S)-6-(2,12-Dihydroxytridecyl)-2,4-dihydroxybenzoic acid

C23H36O6 (408.2512)


   

3,3-dimethyl-1,2,3,4,5,6,1,2,3,4,5,6,9,10-tetradecahydro-[9,10]bi[1,5-methano-pyrido[1,2-a][1,5]diazocinyl]-8,8-dione|Dimethamin

3,3-dimethyl-1,2,3,4,5,6,1,2,3,4,5,6,9,10-tetradecahydro-[9,10]bi[1,5-methano-pyrido[1,2-a][1,5]diazocinyl]-8,8-dione|Dimethamin

C24H32N4O2 (408.2525)


   

SCHEMBL15100585

SCHEMBL15100585

C26H32O4 (408.23)


   
   

prugosene C1

prugosene C1

C27H36O3 (408.2664)


   

4-hydroxy-5-methoxy-8,8-bis(3-methylbut-2-enyl)-2-phenyl-3,4-dihydro-2H-chromen-7(8H)-one|pongaflavanol

4-hydroxy-5-methoxy-8,8-bis(3-methylbut-2-enyl)-2-phenyl-3,4-dihydro-2H-chromen-7(8H)-one|pongaflavanol

C26H32O4 (408.23)


   

2,4-Dihydroxy-3,5-bis(3-methyl-2-butenyl)-6-phenethylbenzoic acid methyl ester

2,4-Dihydroxy-3,5-bis(3-methyl-2-butenyl)-6-phenethylbenzoic acid methyl ester

C26H32O4 (408.23)


   

(1R*,2R*,3R*,6S*,7S*,9R*,10R*,14R*)-3-butanoyloxycladiell-11(17)-en-6,7-diol

(1R*,2R*,3R*,6S*,7S*,9R*,10R*,14R*)-3-butanoyloxycladiell-11(17)-en-6,7-diol

C24H40O5 (408.2876)


   

4-hydroxy-5-(11-hydroxy-3,7,11-trimethyldodeca-2,6-dienyl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

4-hydroxy-5-(11-hydroxy-3,7,11-trimethyldodeca-2,6-dienyl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

C24H40O5 (408.2876)


   

methyl 6beta-hydroxy-18-acetoxy-grindelane methyl ester

methyl 6beta-hydroxy-18-acetoxy-grindelane methyl ester

C23H36O6 (408.2512)


   

(?)-9,10-epoxymuqubilin A

(?)-9,10-epoxymuqubilin A

C24H40O5 (408.2876)


   

palmadorin J

palmadorin J

C23H36O6 (408.2512)


   

(R)-3,5-dihydroxy-7-(16-hydroxyheptadecyl)benzoic acid

(R)-3,5-dihydroxy-7-(16-hydroxyheptadecyl)benzoic acid

C24H40O5 (408.2876)


   

palmadorin E

palmadorin E

C23H36O6 (408.2512)


   

(R)-3,5-dihydroxy-7-(15-hydroxyheptadecyl)benzoic acid

(R)-3,5-dihydroxy-7-(15-hydroxyheptadecyl)benzoic acid

C24H40O5 (408.2876)


   
   

grayanotoxin XXII

grayanotoxin XXII

C23H36O6 (408.2512)


   

15,18-diacetyl-trinertriol

15,18-diacetyl-trinertriol

C24H40O5 (408.2876)


   

dimethyl (14S)-(2E,6E,10Z)-6-methoxycarbonyl-2,10,14-trimethylhexadeca-2,6,10-trienedioate

dimethyl (14S)-(2E,6E,10Z)-6-methoxycarbonyl-2,10,14-trimethylhexadeca-2,6,10-trienedioate

C23H36O6 (408.2512)


   

(2R)-6-(2-acetoxytridecyl)-5-formyl-2-methoxy-1,4-dihydroxybenzene

(2R)-6-(2-acetoxytridecyl)-5-formyl-2-methoxy-1,4-dihydroxybenzene

C23H36O6 (408.2512)


   

Licoricidin

Licoricidin

C26H32O4 (408.23)


   

(rel 5S,6R,8R,9R,10S,13S)-6-acetoxy-9,13-epoxy-15-methoxy-labdan-16,15-olide

(rel 5S,6R,8R,9R,10S,13S)-6-acetoxy-9,13-epoxy-15-methoxy-labdan-16,15-olide

C23H36O6 (408.2512)


   

2-hydroxy-4-methoxy-5,6-O-(4-isopropyl-1beta-methyl-cyclohexane-1-O,5-yl)dihydrochalcone

2-hydroxy-4-methoxy-5,6-O-(4-isopropyl-1beta-methyl-cyclohexane-1-O,5-yl)dihydrochalcone

C26H32O4 (408.23)


   

Byssomeruliol E

Byssomeruliol E

C24H40O5 (408.2876)


   

3-Ac-3,11,17,21-Tetrahydroxypregnan-20-one,

3-Ac-3,11,17,21-Tetrahydroxypregnan-20-one,

C23H36O6 (408.2512)


   

6-beta-hydroxy-17-acetoxy-grindelane methyl ester

6-beta-hydroxy-17-acetoxy-grindelane methyl ester

C23H36O6 (408.2512)


   

2-carboxy-5-hydroxy-3-methoxy-4-geranylbibenzyl

2-carboxy-5-hydroxy-3-methoxy-4-geranylbibenzyl

C26H32O4 (408.23)


   

ambiguine A|ambiguine A isonitrile

ambiguine A|ambiguine A isonitrile

C26H33ClN2 (408.2332)


   

(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide|(rel 5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide

(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide|(rel 5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide

C23H36O6 (408.2512)


   

MS000198706

MS000198706

C26H32O4 (408.23)


   

(15R)-PGE(2)-Methylester-15-Acetat

(15R)-PGE(2)-Methylester-15-Acetat

C23H36O6 (408.2512)


   

tarapacol diacetate

tarapacol diacetate

C24H40O5 (408.2876)


   

ent-16alpha-hydroxy-2alpha-hydroxybenzylatis-13-en-3-one

ent-16alpha-hydroxy-2alpha-hydroxybenzylatis-13-en-3-one

C27H36O3 (408.2664)


   

Dendrillolide D

Dendrillolide D

C23H36O6 (408.2512)


   

callophycoic acid F

callophycoic acid F

C27H36O3 (408.2664)


An organic heterobicyclic compound that is 2,5-dihydro-1-benzoxepine-7-carboxylic acid substituted by a (3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl group at position 3. It is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.

   

19-hydroxy-17-acetoxy-grindelane methyl ester

19-hydroxy-17-acetoxy-grindelane methyl ester

C23H36O6 (408.2512)


   

Aspergillus acid A

Aspergillus acid A

C24H40O5 (408.2876)


   

(+)-Coriolin B|coriolin B

(+)-Coriolin B|coriolin B

C23H36O6 (408.2512)


   

ptychantin M

ptychantin M

C24H40O5 (408.2876)


   

methyl-6alpha,18-dihydroxy-17-acetoxy-kolavenoate

methyl-6alpha,18-dihydroxy-17-acetoxy-kolavenoate

C23H36O6 (408.2512)


   

3,11-diacetoxy-15,16-dehydrocembran-6-one

3,11-diacetoxy-15,16-dehydrocembran-6-one

C24H40O5 (408.2876)


   

15-O-succinylisocupressic acid

15-O-succinylisocupressic acid

C23H36O6 (408.2512)


   

tyrosylvalyllysine

tyrosylvalyllysine

C20H32N4O5 (408.2373)


   

prolylhistidylarginine

prolylhistidylarginine

C17H28N8O4 (408.2233)


   
   
   
   
   
   

valyltyrosyllysine

valyltyrosyllysine

C20H32N4O5 (408.2373)


   
   

3alpha,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3, 7 and 12 (the 3beta,7alpha,12alpha stereoisomer). [Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3alpha,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3alpha,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3alpha,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7alpha,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

1b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

1b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

1b,3a,12a-Trihydroxy-5b-cholan-24-Oic acid

1b,3a,12a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

2b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

2b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

2b,3a,12a-Trihydroxy-5b-cholan-24-oic acid

2b,3a,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,4b,7a-Trihydroxy-5b-cholan-24-Oic acid

3a,4b,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3b,4b,7a-Trihydroxy-5b-cholan-24-oic acid

3b,4b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,4b,12a-Trihydroxy-5b-cholan-24-oic acid

3a,4b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3b,4b,12a-Trihydroxy-5b-cholan-24-oic acid

3b,4b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3b,4a,12a-Trihydroxy-5b-cholan-24-oic acid

3b,4a,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,6a,7a-Trihydroxy-5b-cholan-24-Oic acid

3a,6a,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay [Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-source decay

   

3a,6a,7b-Trihydroxy-5b-cholan-24-Oic acid

3a,6a,7b-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay In-suorce decay; [Mass_spectrometry] Sampling interval 1 Hz; [Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3a,6b,7a-Trihydroxy-5b-cholan-24-oic acid

3a,6b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3a,6b,7b-Trihydroxy-5b-cholan-24-Oic acid

3a,6b,7b-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6a,7a-Trihydroxy-5b-cholan-24-oic acid

3b,6a,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6a,7b-Trihydroxy-5b-cholan-24-oic acid

3b,6a,7b-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6b,7a-Trihydroxy-5b-cholan-24-oic acid

3b,6b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6b,7b-Trihydroxy-5b-cholan-24-oic acid

3b,6b,7b-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3a,6a,12a-Trihydroxy-5b-cholan-24-Oic acid

3a,6a,12a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay In-suorce decay; [Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,6b,12a-Trihydroxy-5b-cholan-24-oic acid

3a,6b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6a,12a-Trihydroxy-5b-cholan-24-oic acid

3b,6a,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6b,12a-Trihydroxy-5b-cholan-24-oic acid

3b,6b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   
   

C24H40O5_4-{[5-(7-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

NCGC00380160-01_C24H40O5_4-{[5-(7-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

C24H40O5 (408.2876)


   

C24H40O5_4-{[5-(6-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

NCGC00380550-01_C24H40O5_4-{[5-(6-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

C24H40O5 (408.2876)


   

C23H36O6_1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (betaR,deltaR,1S,2S,8S,8aR)

NCGC00169628-03_C23H36O6_1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (betaR,deltaR,1S,2S,8S,8aR)-

C23H36O6 (408.2512)


   

3a,6a,7b-Trihydroxy-5b-cholanoic acid

3a,6a,7b-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

2-hydroxy-4-methoxy-3,5-bis(3-methylbut-2-enyl)-6-(2-phenylethyl)benzoic acid

2-hydroxy-4-methoxy-3,5-bis(3-methylbut-2-enyl)-6-(2-phenylethyl)benzoic acid

C26H32O4 (408.23)


   

(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

C23H36O6 (408.2512)


   

3-Cholic acid

3-Cholic acid

C24H40O5 (408.2876)


CONFIDENCE standard compound; INTERNAL_ID 301

   

3a,6a,7b-(OH)3-5a-cholanic acid

3a,6a,7b-(OH)3-5a-cholanic acid

C24H40O5 (408.2876)


BA-99-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-99-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-99-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,6b,7b-Trihydroxy-5a-cholan-24-oic acid

3a,6b,7b-Trihydroxy-5a-cholan-24-oic acid

C24H40O5 (408.2876)


BA-100-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-100-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-100-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,14a-(OH)3-5b-cholanic acid

3a,7a,14a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-103-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-103-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-103-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-103-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7b,14a-(OH)3-5b-cholanic acid

3a,7b,14a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-104-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-104-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-104-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-104-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,15a-(OH)3-5b-cholanic acid

3a,7a,15a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-105-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-105-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-105-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-105-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,15b-(OH)3-5b-cholanic acid

3a,7a,15b-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-106-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-106-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-106-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-106-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7b,15b-(OH)3-5b-cholanic acid

3a,7b,15b-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-107-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-107-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-107-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-107-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,16a-(OH)3-5b-cholanic acid

3a,7a,16a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-108-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-108-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-108-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,16b-(OH)3-5b-cholanic acid

3a,7a,16b-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-109-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,17a-(OH)3-5b-cholanic acid

3a,7a,17a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-110-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-110-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   
   

Cholic acid; LC-tDDA; CE10

Cholic acid; LC-tDDA; CE10

C24H40O5 (408.2876)


   

Cholic acid; LC-tDDA; CE20

Cholic acid; LC-tDDA; CE20

C24H40O5 (408.2876)


   

Cholic acid; LC-tDDA; CE30

Cholic acid; LC-tDDA; CE30

C24H40O5 (408.2876)


   

Cholic acid; LC-tDDA; CE40

Cholic acid; LC-tDDA; CE40

C24H40O5 (408.2876)


   

Ursocholic acid

3alpha,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


A bile acid that is 5beta-cholan-24-oic acid bearing three hydroxy substituents at positions 3alpha, 7beta and 12alpha. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Ursocholic acid, a bile acid found predominantly in bile of mammals, is transformed into deoxycholic acid by the intestinal microflora in mice. Ursodeoxycholic acid is an inhibitor of 7α-hydroxysteroid dehydrogenase and hepatocyte nuclear factor 1α[1].

   

Cholic Acid_major

Cholic Acid_major

C24H40O5 (408.2876)


   

(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid_major

(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid_major

C23H36O6 (408.2512)


   

Cholic Acid_88.5\\%

Cholic Acid_88.5\\%

C24H40O5 (408.2876)


   

(R)-4-((3R,5S,7S,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,7S,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((1R,3S,5S,7R,8S,9S,10S,13R,14S,17R)-1,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((1R,3S,5S,7R,8S,9S,10S,13R,14S,17R)-1,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7R,8R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7R,8R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6R,8R,9S,10R,12S,13R,14S,17R)-3,6,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6R,8R,9S,10R,12S,13R,14S,17R)-3,6,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3S,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3S,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6R,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6R,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   
   
   

Dextromoramide M2

Dextromoramide M2

C25H32N2O3 (408.2413)


   

Dextromoramide M3

Dextromoramide M3

C25H32N2O3 (408.2413)


   

Pro Pro Pro Val

(2S)-3-methyl-2-{[(2S)-1-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanoic acid

C20H32N4O5 (408.2373)


   

Pro Pro Val Pro

(2S)-1-[(2S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O5 (408.2373)


   

Pro Val Pro Pro

(2S)-1-{[(2S)-1-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O5 (408.2373)


   
   
   
   
   

Val Pro Pro Pro

(2S)-1-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O5 (408.2373)


   

Diacetyl-8-gingerdiol

Diacetyl-8-gingerdiol

C23H36O6 (408.2512)


   

Methyl bixin/ (Bixin dimethyl ester)

Methyl bixin/ (Bixin dimethyl ester)

C26H32O4 (408.23)


   

O-2545 (hydrochloride)

6a,7,10,10a-tetrahydro-3-[5-(1H-imidazol-1-yl)-1,1-dimethylpentyl]-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, monohydrochloride

C26H36N2O2 (408.2777)


   

CAY10570

3-decyl-5,5-diphenyl-2-thioxo-4-imidazolidinone

C25H32N2OS (408.2235)


   

15R-PGE2 methyl ester, 15-acetate

methyl 9-oxo-11R-hydroxy-15R-acetoxy-5Z,13E-prostadienoate

C23H36O6 (408.2512)


   

PA(16:1(9Z)/0:0)

1-(9Z-hexadecenoyl)-glycero-3-phosphate

C19H37O7P (408.2277)


   

cis-Methylbixin

1,20-dimethyl (2Z,4Z,6E,8Z,10E,12E,14Z,16Z,18E)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

C26H32O4 (408.23)


   

Sinapoylspermine

(2Z)-N-(3-aminopropyl)-N-{4-[(3-aminopropyl)amino]butyl}-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enamide

C21H36N4O4 (408.2736)


   

Apoviolaxanthinal

(2Z,4Z,6E,8E,10E,12Z,14E)-15-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenal

C27H36O3 (408.2664)


   

Isomethylbixin

1,20-dimethyl (2Z,4Z,6Z,8E,10E,12Z,14E,16Z,18Z)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

C26H32O4 (408.23)


   

Heterophylol

6a,7,12,12a-tetrahydro-9,11-Dimethoxy-6,6-dimethyl-8-(3-methyl-2-butenyl)-6H-benzo[b]naphtho[2,3-D]pyran-3-ol, 9ci

C26H32O4 (408.23)


   

(3R,5R)-3,5-Dihydroxy-7-{(1S,2S,8S,8aR)-2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}heptanoic acid

(3R,5R)-3,5-Dihydroxy-7-{(1S,2S,8S,8aR)-2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}heptanoic acid

C23H36O6 (408.2512)


   

FA 23:5;O4

methyl 9-oxo-11R-hydroxy-15R-acetoxy-5Z,13E-prostadienoate

C23H36O6 (408.2512)


   

LPA 16:1

1-(9Z-hexadecenoyl)-glycero-3-phosphate

C19H37O7P (408.2277)


   

1-palmitoylglycerone 3-phosphate

1-hexadecanoyl-glycerone 3-phosphate

C19H37O7P (408.2277)


   

1-heptadecylglycerone 3-phosphate

1-heptadecyl glycerone-3-phosphate

C20H41O6P (408.2641)


A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as heptadecyl.

   

Methyl bixin

Dimethyl 6,6-diapocarotene-6,6-dioate

C26H32O4 (408.23)


   
   

tetrakis(dimethylamino)tin

tetrakis(dimethylamino)tin

C16H40N4Sn (408.2275)


   

METHYL 4 4 5 5-TETRAMETHYL-ALPHA-(1-(4

METHYL 4 4 5 5-TETRAMETHYL-ALPHA-(1-(4

C21H38B2O6 (408.2854)


   
   

Tetrakis(diethylamine)tin

Tetrakis(diethylamine)tin

C16H40N4Sn (408.2275)


   

(17β)-17-(1-Cyclohexen-1-yloxy)estra-1,3,5(10)-trien-3-yl propion ate

(17β)-17-(1-Cyclohexen-1-yloxy)estra-1,3,5(10)-trien-3-yl propion ate

C27H36O3 (408.2664)


   

4-tert-butylphenol,formaldehyde,4-[2-(4-hydroxyphenyl)propyl]phenol

4-tert-butylphenol,formaldehyde,4-[2-(4-hydroxyphenyl)propyl]phenol

C26H32O4 (408.23)


   

2,2-AZOBIS[2-METHYL-N-[1,1-BIS(HYDROXYMETHYL)-2-HYDROXYETHYL]PROPIONAMIDE]

2,2-AZOBIS[2-METHYL-N-[1,1-BIS(HYDROXYMETHYL)-2-HYDROXYETHYL]PROPIONAMIDE]

C16H32N4O8 (408.222)


   

4-Propoxyphenyl-4-Trans-PentylcyclohexylBenzoat

4-Propoxyphenyl-4-Trans-PentylcyclohexylBenzoat

C27H36O3 (408.2664)


   

Lofentanil

Lofentanil

C25H32N2O3 (408.2413)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Diethylstilbestrol Dibutyrate

Diethylstilbestrol Dibutyrate

C26H32O4 (408.23)


   

TRIS(BUTYLCYCLOPENTADIENYL)SCANDIUM(III&

TRIS(BUTYLCYCLOPENTADIENYL)SCANDIUM(III&

C27H39Sc (408.2611)


   

YH5RAY1N4B

YH5RAY1N4B

C26H32O4 (408.23)


   

Propargyl-PEG8-OH

Propargyl-PEG8-OH

C19H36O9 (408.2359)


   

4-Pentyloxyphenyl-4-Trans-PropylcyclohexylBenzo

4-Pentyloxyphenyl-4-Trans-PropylcyclohexylBenzo

C27H36O3 (408.2664)


   

QUINGESTANOL ACETATE

QUINGESTANOL ACETATE

C27H36O3 (408.2664)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

Mevinic acid

Mevinic acid

C23H36O6 (408.2512)


   

1H-Pyrazole-5-carboxamide, 3-(3-(dimethylamino)propoxy)-N-(4-methoxyphenyl)-1-(phenylmethyl)-

1H-Pyrazole-5-carboxamide, 3-(3-(dimethylamino)propoxy)-N-(4-methoxyphenyl)-1-(phenylmethyl)-

C23H28N4O3 (408.2161)


   

2-[4-(Dimethylamino)phenyl]azobenzoic acid [2-(1-azepanyl)-2-oxoethyl] ester

2-[4-(Dimethylamino)phenyl]azobenzoic acid [2-(1-azepanyl)-2-oxoethyl] ester

C23H28N4O3 (408.2161)


   

3,4-Dihydro-2,5,7,8-tetramethyl-2-[2-(4-benzyl-1-piperazinyl)ethyl]-2H-1-benzopyran-6-ol

3,4-Dihydro-2,5,7,8-tetramethyl-2-[2-(4-benzyl-1-piperazinyl)ethyl]-2H-1-benzopyran-6-ol

C26H36N2O2 (408.2777)


   

Carbobenzyloxy-(L)-leucinyl-(L)leucinyl methoxymethylketone

Carbobenzyloxy-(L)-leucinyl-(L)leucinyl methoxymethylketone

C22H36N2O5 (408.2624)


   

3,5-Dihydroxy-7-[2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid

3,5-Dihydroxy-7-[2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid

C23H36O6 (408.2512)


   

1-Palmitoyl-sn-glycerol 3-phosphate(2-)

1-Palmitoyl-sn-glycerol 3-phosphate(2-)

C19H37O7P-2 (408.2277)


   

2-Palmitoyl-sn-glycerol 3-phosphate

2-Palmitoyl-sn-glycerol 3-phosphate

C19H37O7P-2 (408.2277)


   

5,6-Epoxy-3-hydroxy-12-apo-beta-caroten-12-al

5,6-Epoxy-3-hydroxy-12-apo-beta-caroten-12-al

C27H36O3 (408.2664)


   

3,5-Dihydroxy-6,7-didehydro-12-apo-beta-caroten-12-al

3,5-Dihydroxy-6,7-didehydro-12-apo-beta-caroten-12-al

C27H36O3 (408.2664)


   

[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate

[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate

C19H37O7P (408.2277)


   

MG(PGJ2/0:0/0:0)

MG(PGJ2/0:0/0:0)

C23H36O6 (408.2512)


   

MG(0:0/PGJ2/0:0)

MG(0:0/PGJ2/0:0)

C23H36O6 (408.2512)


   

1-[2-Imino-3-[2-(1-piperidinyl)ethyl]-1-benzimidazolyl]-3-(3-methylphenoxy)-2-propanol

1-[2-Imino-3-[2-(1-piperidinyl)ethyl]-1-benzimidazolyl]-3-(3-methylphenoxy)-2-propanol

C24H32N4O2 (408.2525)


   
   

1-[3-(dimethylamino)propyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-phenylurea

1-[3-(dimethylamino)propyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-phenylurea

C23H28N4O3 (408.2161)


   

1-[2-(dimethylamino)ethyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)urea

1-[2-(dimethylamino)ethyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)urea

C23H28N4O3 (408.2161)


   

N-[3-(2,6-dimethyl-1-piperidinyl)propyl]-1,5-dimethyl-4-oxo-2-pyrrolo[3,2-c]quinolinecarboxamide

N-[3-(2,6-dimethyl-1-piperidinyl)propyl]-1,5-dimethyl-4-oxo-2-pyrrolo[3,2-c]quinolinecarboxamide

C24H32N4O2 (408.2525)


   

2-oxo-3-[(8S)-epoxy-(2E,6E)-farnesyl]-6-(pyridin-3-yl)-2H-pyran-4-olate

2-oxo-3-[(8S)-epoxy-(2E,6E)-farnesyl]-6-(pyridin-3-yl)-2H-pyran-4-olate

C25H30NO4- (408.2175)


   
   
   

(1S,9R,10R,11R)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H28N4O3 (408.2161)


   

cyclopentyl-[(2R,3R)-6-[(4-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]methanone

cyclopentyl-[(2R,3R)-6-[(4-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]methanone

C25H29FN2O2 (408.2213)


   

(2R,3R)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2R,3R)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H28N4O3 (408.2161)


   

1-[(2S,3S)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone

1-[(2S,3S)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone

C25H29FN2O2 (408.2213)


   

(2S,3S)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2S,3S)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H28N4O3 (408.2161)


   

(1R,9S,10S,11S)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H28N4O3 (408.2161)


   

[(8S,9R,10R)-9-[4-(1-cyclopentenyl)phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8S,9R,10R)-9-[4-(1-cyclopentenyl)phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C23H31F3N2O (408.2388)


   

1-[(2S,3S)-1-[(3-fluorophenyl)methyl]-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]propan-1-one

1-[(2S,3S)-1-[(3-fluorophenyl)methyl]-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]propan-1-one

C25H29FN2O2 (408.2213)


   

1-[(2R,3R)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone

1-[(2R,3R)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone

C25H29FN2O2 (408.2213)


   

1-[(2S,3R)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone

1-[(2S,3R)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone

C25H29FN2O2 (408.2213)


   

(2S,3R)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2S,3R)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H28N4O3 (408.2161)


   
   
   
   
   
   
   
   
   
   

1-Palmitoylglycerol 3-phosphate(2-)

1-Palmitoylglycerol 3-phosphate(2-)

C19H37O7P-2 (408.2277)


   

(2S,3R)-3-farnesyl-2,3-dihydro-2,N(alpha)-cyclo-L-tryptophan

(2S,3R)-3-farnesyl-2,3-dihydro-2,N(alpha)-cyclo-L-tryptophan

C26H36N2O2 (408.2777)


   

ethyl 2,7,7-trimethyl-4-(1-methyl-3,4-dihydro-2H-quinolin-6-yl)-5-oxo-3,4,6,8-tetrahydroquinoline-3-carboxylate

ethyl 2,7,7-trimethyl-4-(1-methyl-3,4-dihydro-2H-quinolin-6-yl)-5-oxo-3,4,6,8-tetrahydroquinoline-3-carboxylate

C25H32N2O3 (408.2413)


   

N-(6-aminohexyl)-2-(3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)acetamide

N-(6-aminohexyl)-2-(3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)acetamide

C23H28N4O3 (408.2161)


   

1-Palmitoleoylglycerol 3-phosphate

1-Palmitoleoylglycerol 3-phosphate

C19H37O7P (408.2277)


   

Mgdg O-8:0_2:0

Mgdg O-8:0_2:0

C19H36O9 (408.2359)


   

[(E)-2-(butanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C18H37N2O6P (408.2389)


   

[(E)-3-hydroxy-2-(propanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C18H37N2O6P (408.2389)


   

[(E)-2-acetamido-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C18H37N2O6P (408.2389)


   

[(E)-3-hydroxy-2-(pentanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C18H37N2O6P (408.2389)


   

3-hydroxy-1,2-dimethyl-4-[4-methyl-2-[(E)-2-methyltetradec-4-en-6,8-diynyl]-3,4-dihydro-2H-pyrrol-5-yl]-2H-pyrrol-5-one

3-hydroxy-1,2-dimethyl-4-[4-methyl-2-[(E)-2-methyltetradec-4-en-6,8-diynyl]-3,4-dihydro-2H-pyrrol-5-yl]-2H-pyrrol-5-one

C26H36N2O2 (408.2777)


   

trans-Methylbixin

trans-Methylbixin

C26H32O4 (408.23)


   

lofentanyl

lofentanyl

C25H32N2O3 (408.2413)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

1-(9Z-hexadecenoyl)-glycero-3-phosphate

1-(9Z-hexadecenoyl)-glycero-3-phosphate

C19H37O7P (408.2277)


   

Apo-10-violaxanthal

Apo-10-violaxanthal

C27H36O3 (408.2664)


   

1-Palmitoylglycerol 3-phosphate(2-)

1-Palmitoylglycerol 3-phosphate(2-)

C19H37O7P (408.2277)


An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 1-palmitoylglycerol 3-phosphate; major species at pH 7.3.

   

1-palmitoleoyl-sn-glycerol 3-phosphate

1-palmitoleoyl-sn-glycerol 3-phosphate

C19H37O7P (408.2277)


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as palmitoleoyl.

   

1-Palmitoyl-sn-glycerol 3-phosphate(2-)

1-Palmitoyl-sn-glycerol 3-phosphate(2-)

C19H37O7P (408.2277)


Dianion of 1-palmitoyl-sn-glycerol 3-phosphate arising from deprotonation of both OH groups of the phosphate.

   

BisMePA(14:1)

BisMePA(8:1(1)_6:0)

C19H37O7P (408.2277)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(20:3)

TG(4:0_6:0_10:3)

C23H36O6 (408.2512)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

PA O-14:1/2:0

PA O-14:1/2:0

C19H37O7P (408.2277)


   
   

PA P-14:0/2:0

PA P-14:0/2:0

C19H37O7P (408.2277)


   

PA P-14:0/2:0 or PA O-14:1/2:0

PA P-14:0/2:0 or PA O-14:1/2:0

C19H37O7P (408.2277)


   
   

PA P-16:0 or PA O-16:1

PA P-16:0 or PA O-16:1

C19H37O7P (408.2277)


   
   
   
   
   

ST 26:7;O4

ST 26:7;O4

C26H32O4 (408.23)


   
   

LSM(14:1)

LSM(d14:1)

C19H41N2O5P (408.2753)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CYM51010

CYM51010

C25H32N2O3 (408.2413)


CYM51010 is a biased ligand of μ-opioid receptor – δ-opioid receptor heterodimers with an EC50 of 403 nM. CYM51010 exhibits anti-nociceptive activity similar to morphine but with a decreased levels of tolerance development and withdrawal symptoms[1].

   

ω-muricholate

(4R)-4-[(1S,2R,5R,7R,8R,9R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


-

   

methyl (1r,2s,5e)-2-[(2e,5s)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

methyl (1r,2s,5e)-2-[(2e,5s)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

C23H36O6 (408.2512)


   

(1e,5e)-1-[6-(2,3-dihydroxy-3-methylbutyl)-3-hydroxy-2-(hydroxymethyl)phenyl]undeca-1,5-diene-3,4-diol

(1e,5e)-1-[6-(2,3-dihydroxy-3-methylbutyl)-3-hydroxy-2-(hydroxymethyl)phenyl]undeca-1,5-diene-3,4-diol

C23H36O6 (408.2512)


   

3,4,5,7-tetraethyl-1-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

3,4,5,7-tetraethyl-1-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

1-{2,6-dihydroxy-3-[(1s,6s)-6-isopropyl-3-methylcyclohex-2-en-1-yl]-4-methoxyphenyl}-3-phenylpropan-1-one

1-{2,6-dihydroxy-3-[(1s,6s)-6-isopropyl-3-methylcyclohex-2-en-1-yl]-4-methoxyphenyl}-3-phenylpropan-1-one

C26H32O4 (408.23)


   

3-[(2e)-7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl]-2,4-dihydroxy-6-methylbenzoic acid

3-[(2e)-7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl]-2,4-dihydroxy-6-methylbenzoic acid

C23H36O6 (408.2512)


   

(3r)-n-{2-[(7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

(3r)-n-{2-[(7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

C22H36N2O5 (408.2624)


   

5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C23H36O6 (408.2512)


   

1-(2-hydroxy-6-{[(1s,4r)-1-isopropyl-4-methylcyclohex-2-en-1-yl]oxy}-4-methoxyphenyl)-3-phenylpropan-1-one

1-(2-hydroxy-6-{[(1s,4r)-1-isopropyl-4-methylcyclohex-2-en-1-yl]oxy}-4-methoxyphenyl)-3-phenylpropan-1-one

C26H32O4 (408.23)


   

4-hydroxy-4-[2-(2-methoxy-5-oxo-2h-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

4-hydroxy-4-[2-(2-methoxy-5-oxo-2h-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

C23H36O6 (408.2512)


   

1-(2-hydroxy-6-{[(1r)-1-isopropyl-4-methylcyclohex-3-en-1-yl]oxy}-4-methoxyphenyl)-3-phenylpropan-1-one

1-(2-hydroxy-6-{[(1r)-1-isopropyl-4-methylcyclohex-3-en-1-yl]oxy}-4-methoxyphenyl)-3-phenylpropan-1-one

C26H32O4 (408.23)


   

4-[(2s,2ar,7as)-4,6-dimethoxy-1,1-dimethyl-3-(3-methylbut-2-en-1-yl)-2h,2ah,7h,7ah-cyclobuta[a]inden-2-yl]benzene-1,2-diol

4-[(2s,2ar,7as)-4,6-dimethoxy-1,1-dimethyl-3-(3-methylbut-2-en-1-yl)-2h,2ah,7h,7ah-cyclobuta[a]inden-2-yl]benzene-1,2-diol

C26H32O4 (408.23)


   

methyl 2-[(1r,3s,4e,7e,11s,12r)-11-(acetyloxy)-3,12-dihydroxy-4,8,12-trimethylcyclotetradeca-4,7-dien-1-yl]prop-2-enoate

methyl 2-[(1r,3s,4e,7e,11s,12r)-11-(acetyloxy)-3,12-dihydroxy-4,8,12-trimethylcyclotetradeca-4,7-dien-1-yl]prop-2-enoate

C23H36O6 (408.2512)


   

6-[3-(4-hydroxy-2-methoxyphenyl)propyl]-2,2-dimethyl-5-(3-methylbut-2-en-1-yl)chromen-8-ol

6-[3-(4-hydroxy-2-methoxyphenyl)propyl]-2,2-dimethyl-5-(3-methylbut-2-en-1-yl)chromen-8-ol

C26H32O4 (408.23)


   

6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

C26H32O4 (408.23)


   

1,20-dimethyl (6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

1,20-dimethyl (6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

C26H32O4 (408.23)


   

3-hydroxy-n-(2-{3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene}acetyl)tetradecanimidic acid

3-hydroxy-n-(2-{3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene}acetyl)tetradecanimidic acid

C22H36N2O5 (408.2624)


   

asebotoxin ii

NA

C23H36O6 (408.2512)


{"Ingredient_id": "HBIN017047","Ingredient_name": "asebotoxin ii","Alias": "NA","Ingredient_formula": "C23H36O6","Ingredient_Smile": "CCC(=O)OC1C2CCC3C1(CC(C4(C(C3=C)CC(C4(C)C)O)O)O)CC2(C)O","Ingredient_weight": "408.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1849","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "135876151","DrugBank_id": "NA"}

   

(3r)-n-{2-[(1e,7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

(3r)-n-{2-[(1e,7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

C22H36N2O5 (408.2624)


   

1-[2,6-dihydroxy-3-(6-isopropyl-3-methylcyclohex-2-en-1-yl)-4-methoxyphenyl]-3-phenylpropan-1-one

1-[2,6-dihydroxy-3-(6-isopropyl-3-methylcyclohex-2-en-1-yl)-4-methoxyphenyl]-3-phenylpropan-1-one

C26H32O4 (408.23)


   

1-(2-formyl-3,6-dihydroxy-5-methoxyphenyl)tridecan-2-yl acetate

1-(2-formyl-3,6-dihydroxy-5-methoxyphenyl)tridecan-2-yl acetate

C23H36O6 (408.2512)


   

(1s,2s,2''s,4s,4ar,5'r,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

(1s,2s,2''s,4s,4ar,5'r,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

1-{2-hydroxy-6-[(1-isopropyl-4-methylcyclohex-3-en-1-yl)oxy]-4-methoxyphenyl}-3-phenylpropan-1-one

1-{2-hydroxy-6-[(1-isopropyl-4-methylcyclohex-3-en-1-yl)oxy]-4-methoxyphenyl}-3-phenylpropan-1-one

C26H32O4 (408.23)


   

(3s)-3'-[2-(dimethylamino)ethyl]-3,5'-dihydroxy-3-[2-(methylamino)ethyl]-1'h-[1,4'-biindol]-2-one

(3s)-3'-[2-(dimethylamino)ethyl]-3,5'-dihydroxy-3-[2-(methylamino)ethyl]-1'h-[1,4'-biindol]-2-one

C23H28N4O3 (408.2161)


   

(1s,4ar,5r,8as)-5-[(3r)-1-[(3-carboxypropanoyl)oxy]pentan-3-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1s,4ar,5r,8as)-5-[(3r)-1-[(3-carboxypropanoyl)oxy]pentan-3-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C23H36O6 (408.2512)


   

2-({1,3-dihydroxy-2-[(1-hydroxy-6-methyloctylidene)amino]propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

2-({1,3-dihydroxy-2-[(1-hydroxy-6-methyloctylidene)amino]propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

C21H32N2O6 (408.226)


   

3-{[(4ar,5s,6r,8ar)-5-{2-[(3r,5s)-5-hydroxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}-3-oxopropanoic acid

3-{[(4ar,5s,6r,8ar)-5-{2-[(3r,5s)-5-hydroxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}-3-oxopropanoic acid

C23H36O6 (408.2512)


   

(1r,2r,2''s,4as,5's,6s,8as)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

(1r,2r,2''s,4as,5's,6s,8as)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

C23H36O6 (408.2512)


   

5-{1-[(3-carboxypropanoyl)oxy]pentan-3-yl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

5-{1-[(3-carboxypropanoyl)oxy]pentan-3-yl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C23H36O6 (408.2512)


   

(1s,2s,5r,10r,11r,12r,14r,16r,17r)-12,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane-17-carboxylic acid

(1s,2s,5r,10r,11r,12r,14r,16r,17r)-12,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane-17-carboxylic acid

C23H36O6 (408.2512)


   

(3r,6e,10z,14e)-10-[(acetyloxy)methyl]-16-hydroxy-14-(hydroxymethyl)-3,6-dimethyl-2-methylidenehexadeca-6,10,14-trienoic acid

(3r,6e,10z,14e)-10-[(acetyloxy)methyl]-16-hydroxy-14-(hydroxymethyl)-3,6-dimethyl-2-methylidenehexadeca-6,10,14-trienoic acid

C23H36O6 (408.2512)


   

4-[4,6-dimethoxy-1,1-dimethyl-3-(3-methylbut-2-en-1-yl)-2h,2ah,7h,7ah-cyclobuta[a]inden-2-yl]benzene-1,2-diol

4-[4,6-dimethoxy-1,1-dimethyl-3-(3-methylbut-2-en-1-yl)-2h,2ah,7h,7ah-cyclobuta[a]inden-2-yl]benzene-1,2-diol

C26H32O4 (408.23)


   

16-hydroxy-7-[hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

16-hydroxy-7-[hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

C27H36O3 (408.2664)


   

(1s,9r)-11-methyl-5-[(1s,4r,9r)-11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1s,9r)-11-methyl-5-[(1s,4r,9r)-11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C24H32N4O2 (408.2525)


   

(4r,5r)-4-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

(4r,5r)-4-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

C27H36O3 (408.2664)


   

n-[5-chloro-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraen-3-yl]methanimine

n-[5-chloro-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraen-3-yl]methanimine

C26H33ClN2 (408.2332)


   

2-[2-(acetyloxy)tridecyl]-6-hydroxy-4-methoxybenzoic acid

2-[2-(acetyloxy)tridecyl]-6-hydroxy-4-methoxybenzoic acid

C23H36O6 (408.2512)


   

[3-(2-methoxy-2-oxoethyl)-4a,7,7,10a-tetramethyl-2-oxo-octahydro-3h-naphtho[1,2-b]pyran-4-yl]methyl acetate

[3-(2-methoxy-2-oxoethyl)-4a,7,7,10a-tetramethyl-2-oxo-octahydro-3h-naphtho[1,2-b]pyran-4-yl]methyl acetate

C23H36O6 (408.2512)


   

(1s,3s,4s,4ar,8ar)-4-hydroxy-4-{2-[(2r)-2-methoxy-5-oxo-2h-furan-3-yl]ethyl}-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

(1s,3s,4s,4ar,8ar)-4-hydroxy-4-{2-[(2r)-2-methoxy-5-oxo-2h-furan-3-yl]ethyl}-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

C23H36O6 (408.2512)


   

(2r)-2-{[(2r)-1,3-dihydroxy-2-[(1-hydroxy-6-methyloctylidene)amino]propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2r)-2-{[(2r)-1,3-dihydroxy-2-[(1-hydroxy-6-methyloctylidene)amino]propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C21H32N2O6 (408.226)


   

(5r,5as,9r,9ar,9bs)-9,9b-dihydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl octanoate

(5r,5as,9r,9ar,9bs)-9,9b-dihydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl octanoate

C23H36O6 (408.2512)


   

(2s,4s)-4-hydroxy-5-methoxy-8,8-bis(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran-7-one

(2s,4s)-4-hydroxy-5-methoxy-8,8-bis(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran-7-one

C26H32O4 (408.23)


   

(1s,4r,4ar,5s,5'r,8ar)-4-hydroxy-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate

(1s,4r,4ar,5s,5'r,8ar)-4-hydroxy-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate

C23H36O6 (408.2512)


   

(4ar,4br,6ar,11ar,11br,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

(4ar,4br,6ar,11ar,11br,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

C27H36O3 (408.2664)


   

mevastatin5hydroxyacid

mevastatin5hydroxyacid

C23H36O6 (408.2512)


   

4-[5-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

4-[5-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

C27H36O3 (408.2664)


   

(1s,2s,2''r,4s,4ar,5's,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

(1s,2s,2''r,4s,4ar,5's,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

C27H36O3 (408.2664)


   

1-{5-hydroxy-12-isopropyl-3-methoxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl}-3-phenylpropan-1-one

1-{5-hydroxy-12-isopropyl-3-methoxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl}-3-phenylpropan-1-one

C26H32O4 (408.23)


   

5-(2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl)-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

5-(2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl)-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

C23H36O6 (408.2512)


   

(1s,3r,3's,3ar,4s,5r,7ar)-1-(acetyloxy)-3'-methyl-5-(1,3,3-trimethylcyclohexyl)-hexahydro-1h-spiro[2-benzofuran-4,2'-oxiran]-3-yl acetate

(1s,3r,3's,3ar,4s,5r,7ar)-1-(acetyloxy)-3'-methyl-5-(1,3,3-trimethylcyclohexyl)-hexahydro-1h-spiro[2-benzofuran-4,2'-oxiran]-3-yl acetate

C23H36O6 (408.2512)


   

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

C26H32O4 (408.23)


   
   

(1r,4s,7r,9s,10s,12r,16s)-16-hydroxy-7-[(s)-hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

(1r,4s,7r,9s,10s,12r,16s)-16-hydroxy-7-[(s)-hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

C27H36O3 (408.2664)


   

(1e,3s,4s,5e)-1-{6-[(2s)-2,3-dihydroxy-3-methylbutyl]-3-hydroxy-2-(hydroxymethyl)phenyl}undeca-1,5-diene-3,4-diol

(1e,3s,4s,5e)-1-{6-[(2s)-2,3-dihydroxy-3-methylbutyl]-3-hydroxy-2-(hydroxymethyl)phenyl}undeca-1,5-diene-3,4-diol

C23H36O6 (408.2512)


   

1-[(1r,9r,12s)-5-hydroxy-12-isopropyl-3-methoxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl]-3-phenylpropan-1-one

1-[(1r,9r,12s)-5-hydroxy-12-isopropyl-3-methoxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl]-3-phenylpropan-1-one

C26H32O4 (408.23)


   

(4r,5r)-4-{5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl}-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

(4r,5r)-4-{5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl}-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

C27H36O3 (408.2664)


   

2-({1,3-dihydroxy-2-[(1-hydroxy-7-methyloctylidene)amino]propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

2-({1,3-dihydroxy-2-[(1-hydroxy-7-methyloctylidene)amino]propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

C21H32N2O6 (408.226)


   

methyl (2e)-5-[(1r,2r,4s,4ar,8ar)-2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-1,4a-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

methyl (2e)-5-[(1r,2r,4s,4ar,8ar)-2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-1,4a-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

C23H36O6 (408.2512)


   

methyl (3r)-5-[(1r,2s,3s,4as,8ar)-3-(acetyloxy)-6-hydroxy-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoate

methyl (3r)-5-[(1r,2s,3s,4as,8ar)-3-(acetyloxy)-6-hydroxy-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoate

C23H36O6 (408.2512)


   

(3r,5s)-3-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)dodecan-5-yl acetate

(3r,5s)-3-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)dodecan-5-yl acetate

C23H36O6 (408.2512)


   

methyl (1r,2s,5e)-2-[1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

methyl (1r,2s,5e)-2-[1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

C23H36O6 (408.2512)


   

5''-methoxy-2,5,5,8a-tetramethyl-2''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

5''-methoxy-2,5,5,8a-tetramethyl-2''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

(2r)-2-{[(2r)-1,3-dihydroxy-2-{[(6s)-1-hydroxy-6-methyloctylidene]amino}propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2r)-2-{[(2r)-1,3-dihydroxy-2-{[(6s)-1-hydroxy-6-methyloctylidene]amino}propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C21H32N2O6 (408.226)


   

(1s,3s,3ar,4r,5s,7ar)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5s,7ar)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

(1r,3s,6r,8e,10r,13s,14s,16s)-3,6,14-trihydroxy-5,5,9,14-tetramethyl-4-oxotricyclo[11.2.1.0¹,¹⁰]hexadec-8-en-16-yl propanoate

(1r,3s,6r,8e,10r,13s,14s,16s)-3,6,14-trihydroxy-5,5,9,14-tetramethyl-4-oxotricyclo[11.2.1.0¹,¹⁰]hexadec-8-en-16-yl propanoate

C23H36O6 (408.2512)


   

(4s,4ar,5s,7r,8r,8as)-2,5,8-trihydroxy-4-(3-hydroxyprop-2-enoyl)-4,7-dimethyl-3-[(2r)-octan-2-yl]-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

(4s,4ar,5s,7r,8r,8as)-2,5,8-trihydroxy-4-(3-hydroxyprop-2-enoyl)-4,7-dimethyl-3-[(2r)-octan-2-yl]-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C23H36O6 (408.2512)


   

(8s)-10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

(8s)-10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

C26H36N2O2 (408.2777)


   

5-[(2r,5e,7e,9r,10r,11e)-2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl]-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

5-[(2r,5e,7e,9r,10r,11e)-2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl]-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

C23H36O6 (408.2512)


   

n-[(2s,3r,4r,5r,7s)-5-chloro-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraen-3-yl]methanimine

n-[(2s,3r,4r,5r,7s)-5-chloro-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraen-3-yl]methanimine

C26H33ClN2 (408.2332)


   

(1r,2r,2''r,4r,4as,5'r,8as)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

(1r,2r,2''r,4r,4as,5'r,8as)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

(1r,4r,4ar,5'r,8ar)-4-hydroxy-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

(1r,4r,4ar,5'r,8ar)-4-hydroxy-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

C23H36O6 (408.2512)


   

(5r,5as,9r,9ar,9br)-9,9b-dihydroxy-6,6,9a-trimethyl-1-oxo-3h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl octanoate

(5r,5as,9r,9ar,9br)-9,9b-dihydroxy-6,6,9a-trimethyl-1-oxo-3h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl octanoate

C23H36O6 (408.2512)


   

(4s)-4-[(1s,3as,3br,5as,7s,9ar,9bs,11ar)-3a,5a,7-trihydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-4-hydroxyoxolan-2-one

(4s)-4-[(1s,3as,3br,5as,7s,9ar,9bs,11ar)-3a,5a,7-trihydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-4-hydroxyoxolan-2-one

C23H36O6 (408.2512)


   

(1s,2r,4as,5'r,5''r,8as)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

(1s,2r,4as,5'r,5''r,8as)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C23H36O6 (408.2512)


   

(1s,2s,4s,4ar,5'r,5''s,8ar)-5''-methoxy-2,5,5,8a-tetramethyl-2''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

(1s,2s,4s,4ar,5'r,5''s,8ar)-5''-methoxy-2,5,5,8a-tetramethyl-2''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

methyl 2-[(1s,3r,6r,7r,10e,14s)-7-(acetyloxy)-6-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadec-10-en-3-yl]prop-2-enoate

methyl 2-[(1s,3r,6r,7r,10e,14s)-7-(acetyloxy)-6-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadec-10-en-3-yl]prop-2-enoate

C23H36O6 (408.2512)


   

(4r,5r)-4-{10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl}-2,4,5-trimethylcyclopent-2-en-1-one

(4r,5r)-4-{10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl}-2,4,5-trimethylcyclopent-2-en-1-one

C27H36O3 (408.2664)


   

4-{3a,5a,7-trihydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-4-hydroxyoxolan-2-one

4-{3a,5a,7-trihydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-4-hydroxyoxolan-2-one

C23H36O6 (408.2512)


   

5-(hydroxymethyl)-5'-(2-methoxy-2-oxoethyl)-5,5',8a-trimethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

5-(hydroxymethyl)-5'-(2-methoxy-2-oxoethyl)-5,5',8a-trimethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

C23H36O6 (408.2512)


   

methyl (1r,2s,5e)-2-[(2e,5r)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

methyl (1r,2s,5e)-2-[(2e,5r)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

C23H36O6 (408.2512)


   

3-(7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl)-2,4-dihydroxy-6-methylbenzoic acid

3-(7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl)-2,4-dihydroxy-6-methylbenzoic acid

C23H36O6 (408.2512)


   

2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

methyl (1r,2s,5e)-2-[(2e)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

methyl (1r,2s,5e)-2-[(2e)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

C23H36O6 (408.2512)


   

3-({5-[2-(5-hydroxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methoxy)-3-oxopropanoic acid

3-({5-[2-(5-hydroxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methoxy)-3-oxopropanoic acid

C23H36O6 (408.2512)


   

3'-[2-(dimethylamino)ethyl]-3,5'-dihydroxy-3-[2-(methylamino)ethyl]-1'h-[1,4'-biindol]-2-one

3'-[2-(dimethylamino)ethyl]-3,5'-dihydroxy-3-[2-(methylamino)ethyl]-1'h-[1,4'-biindol]-2-one

C23H28N4O3 (408.2161)


   

(2r)-2-{[(2r)-1,3-dihydroxy-2-[(1-hydroxy-7-methyloctylidene)amino]propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2r)-2-{[(2r)-1,3-dihydroxy-2-[(1-hydroxy-7-methyloctylidene)amino]propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C21H32N2O6 (408.226)


   

4-hydroxy-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

4-hydroxy-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

C23H36O6 (408.2512)


   

(4r,5r,6r)-5-[(9s)-9,12-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-3,6-dihydroxy-2-methoxy-4-methylcyclohex-2-en-1-one

(4r,5r,6r)-5-[(9s)-9,12-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-3,6-dihydroxy-2-methoxy-4-methylcyclohex-2-en-1-one

C23H36O6 (408.2512)


   

3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-2-methoxy-6-(2-phenylethyl)benzoic acid

3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-2-methoxy-6-(2-phenylethyl)benzoic acid

C26H32O4 (408.23)


   

methyl 2-[7-(acetyloxy)-6-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadec-10-en-3-yl]prop-2-enoate

methyl 2-[7-(acetyloxy)-6-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadec-10-en-3-yl]prop-2-enoate

C23H36O6 (408.2512)


   

methyl 5-[6-(acetyloxy)-2-formyl-1-hydroxy-1,4,5,7a-tetramethyl-hexahydroinden-4-yl]-3-methylpent-2-enoate

methyl 5-[6-(acetyloxy)-2-formyl-1-hydroxy-1,4,5,7a-tetramethyl-hexahydroinden-4-yl]-3-methylpent-2-enoate

C23H36O6 (408.2512)


   

(1r,4ar,5r,5'r,8ar)-5-(hydroxymethyl)-5'-(2-methoxy-2-oxoethyl)-5,5',8a-trimethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

(1r,4ar,5r,5'r,8ar)-5-(hydroxymethyl)-5'-(2-methoxy-2-oxoethyl)-5,5',8a-trimethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl acetate

C23H36O6 (408.2512)


   

methyl (2e)-5-[(1s,2s,3ar,4r,5s,6r,7ar)-6-(acetyloxy)-2-formyl-1-hydroxy-1,4,5,7a-tetramethyl-hexahydroinden-4-yl]-3-methylpent-2-enoate

methyl (2e)-5-[(1s,2s,3ar,4r,5s,6r,7ar)-6-(acetyloxy)-2-formyl-1-hydroxy-1,4,5,7a-tetramethyl-hexahydroinden-4-yl]-3-methylpent-2-enoate

C23H36O6 (408.2512)


   

methyl 2-[(1s,3r,6s,7s,10e,14s)-7-(acetyloxy)-6-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadec-10-en-3-yl]prop-2-enoate

methyl 2-[(1s,3r,6s,7s,10e,14s)-7-(acetyloxy)-6-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadec-10-en-3-yl]prop-2-enoate

C23H36O6 (408.2512)


   

(1s,2s,4s,4ar,5's,5''r,8ar)-5''-methoxy-2,5,5,8a-tetramethyl-2''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

(1s,2s,4s,4ar,5's,5''r,8ar)-5''-methoxy-2,5,5,8a-tetramethyl-2''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

methyl 5-{2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-1,4a-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl}-3-methylpent-2-enoate

methyl 5-{2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-1,4a-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl}-3-methylpent-2-enoate

C23H36O6 (408.2512)


   

(1s,2s,2''r,4s,4ar,5'r,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

(1s,2s,2''r,4s,4ar,5'r,8ar)-2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-yl acetate

C23H36O6 (408.2512)


   

6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

C27H36O3 (408.2664)


   

3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol

3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol

C26H32O4 (408.23)


   

(6as,12as)-9,11-dimethoxy-6,6-dimethyl-8-(3-methylbut-2-en-1-yl)-6a,7,12,12a-tetrahydro-5-oxatetraphen-3-ol

(6as,12as)-9,11-dimethoxy-6,6-dimethyl-8-(3-methylbut-2-en-1-yl)-6a,7,12,12a-tetrahydro-5-oxatetraphen-3-ol

C26H32O4 (408.23)


   

(4r,5r)-4-[(2e)-5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

(4r,5r)-4-[(2e)-5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

C27H36O3 (408.2664)


   

2-[(2r)-2-(acetyloxy)tridecyl]-6-hydroxy-4-methoxybenzoic acid

2-[(2r)-2-(acetyloxy)tridecyl]-6-hydroxy-4-methoxybenzoic acid

C23H36O6 (408.2512)


   

(2r)-2-{[(2r)-1,3-dihydroxy-2-{[(6r)-1-hydroxy-6-methyloctylidene]amino}propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2r)-2-{[(2r)-1,3-dihydroxy-2-{[(6r)-1-hydroxy-6-methyloctylidene]amino}propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C21H32N2O6 (408.226)


   

5-[(5e,7e,11e)-2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl]-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

5-[(5e,7e,11e)-2,10-dihydroxy-9,11-dimethyltetradeca-5,7,11-trien-1-yl]-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

C23H36O6 (408.2512)


   

(1s,3s,3ar,4r,5s,7ar)-3,4,5,7-tetraethyl-1-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5s,7ar)-3,4,5,7-tetraethyl-1-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

4-hydroxy-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate

4-hydroxy-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate

C23H36O6 (408.2512)


   

2,5,8-trihydroxy-4-(3-hydroxyprop-2-enoyl)-4,7-dimethyl-3-(octan-2-yl)-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

2,5,8-trihydroxy-4-(3-hydroxyprop-2-enoyl)-4,7-dimethyl-3-(octan-2-yl)-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C23H36O6 (408.2512)


   

(2e,6e,10e)-6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

(2e,6e,10e)-6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

C27H36O3 (408.2664)


   

1-[6-(2,3-dihydroxy-3-methylbutyl)-3-hydroxy-2-(hydroxymethyl)phenyl]undeca-1,5-diene-3,4-diol

1-[6-(2,3-dihydroxy-3-methylbutyl)-3-hydroxy-2-(hydroxymethyl)phenyl]undeca-1,5-diene-3,4-diol

C23H36O6 (408.2512)


   

(1s,2r,4as,5's,5''s,8as)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

(1s,2r,4as,5's,5''s,8as)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C23H36O6 (408.2512)


   

2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

2''-methoxy-2,5,5,8a-tetramethyl-5''-oxo-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

C23H36O6 (408.2512)


   

(2r,3s)-9-hydroxy-2,3,8-trimethyl-3-{2-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]ethyl}-2h-naphtho[1,2-b]furan-6,7-dione

(2r,3s)-9-hydroxy-2,3,8-trimethyl-3-{2-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]ethyl}-2h-naphtho[1,2-b]furan-6,7-dione

C26H32O4 (408.23)


   

(1s,3s,4s,4ar,8ar)-4-hydroxy-4-{2-[(5s)-5-methoxy-2-oxo-5h-furan-3-yl]ethyl}-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

(1s,3s,4s,4ar,8ar)-4-hydroxy-4-{2-[(5s)-5-methoxy-2-oxo-5h-furan-3-yl]ethyl}-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

C23H36O6 (408.2512)


   

(3r)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol

(3r)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol

C26H32O4 (408.23)


   

methyl 5-[3-(acetyloxy)-6-hydroxy-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoate

methyl 5-[3-(acetyloxy)-6-hydroxy-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoate

C23H36O6 (408.2512)


   

12,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane-17-carboxylic acid

12,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane-17-carboxylic acid

C23H36O6 (408.2512)


   

11-methyl-5-{11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl}-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

11-methyl-5-{11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl}-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C24H32N4O2 (408.2525)


   

methyl 2-[1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

methyl 2-[1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate

C23H36O6 (408.2512)


   

3-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2,5-dihydro-1-benzoxepine-7-carboxylic acid

3-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2,5-dihydro-1-benzoxepine-7-carboxylic acid

C27H36O3 (408.2664)


   

1,7-dimethyl (1e,3z,7e,11s,12s)-12-hydroxy-4-isopropyl-11-methoxy-11-methylcyclotetradeca-1,3,7-triene-1,7-dicarboxylate

1,7-dimethyl (1e,3z,7e,11s,12s)-12-hydroxy-4-isopropyl-11-methoxy-11-methylcyclotetradeca-1,3,7-triene-1,7-dicarboxylate

C23H36O6 (408.2512)


   

4-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

4-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

C27H36O3 (408.2664)


   

(4ar,4br,6ar,11ar,11bs,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

(4ar,4br,6ar,11ar,11bs,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

C27H36O3 (408.2664)


   

(3s,6e,10z,14e)-10-[(acetyloxy)methyl]-16-hydroxy-14-(hydroxymethyl)-3,6-dimethyl-2-methylidenehexadeca-6,10,14-trienoic acid

(3s,6e,10z,14e)-10-[(acetyloxy)methyl]-16-hydroxy-14-(hydroxymethyl)-3,6-dimethyl-2-methylidenehexadeca-6,10,14-trienoic acid

C23H36O6 (408.2512)


   

1,4,5,7-tetraethyl-3-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

1,4,5,7-tetraethyl-3-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

(6ar,12as)-9,11-dimethoxy-6,6-dimethyl-8-(3-methylbut-2-en-1-yl)-6a,7,12,12a-tetrahydro-5-oxatetraphen-3-ol

(6ar,12as)-9,11-dimethoxy-6,6-dimethyl-8-(3-methylbut-2-en-1-yl)-6a,7,12,12a-tetrahydro-5-oxatetraphen-3-ol

C26H32O4 (408.23)


   

1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione

1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione

C26H32O4 (408.23)


   

10-[(acetyloxy)methyl]-16-hydroxy-14-(hydroxymethyl)-3,6-dimethyl-2-methylidenehexadeca-6,10,14-trienoic acid

10-[(acetyloxy)methyl]-16-hydroxy-14-(hydroxymethyl)-3,6-dimethyl-2-methylidenehexadeca-6,10,14-trienoic acid

C23H36O6 (408.2512)


   

5-(9,12-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-3,6-dihydroxy-2-methoxy-4-methylcyclohex-2-en-1-one

5-(9,12-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-3,6-dihydroxy-2-methoxy-4-methylcyclohex-2-en-1-one

C23H36O6 (408.2512)


   

4-hydroxy-4-[2-(5-methoxy-2-oxo-5h-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

4-hydroxy-4-[2-(5-methoxy-2-oxo-5h-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate

C23H36O6 (408.2512)


   

3,6,14-trihydroxy-5,5,9,14-tetramethyl-4-oxotricyclo[11.2.1.0¹,¹⁰]hexadec-8-en-16-yl propanoate

3,6,14-trihydroxy-5,5,9,14-tetramethyl-4-oxotricyclo[11.2.1.0¹,¹⁰]hexadec-8-en-16-yl propanoate

C23H36O6 (408.2512)


   

(2r)-1-(2-formyl-3,6-dihydroxy-5-methoxyphenyl)tridecan-2-yl acetate

(2r)-1-(2-formyl-3,6-dihydroxy-5-methoxyphenyl)tridecan-2-yl acetate

C23H36O6 (408.2512)


   

10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

C26H36N2O2 (408.2777)


   

(1r,3r,3as,4s,5s,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1r,3r,3as,4s,5s,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

3-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-2-methoxy-6-(2-phenylethyl)benzoic acid

3-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-2-methoxy-6-(2-phenylethyl)benzoic acid

C26H32O4 (408.23)


   

1,20-dimethyl (6e,8e,10e,12e,14e,16z)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

1,20-dimethyl (6e,8e,10e,12e,14e,16z)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate

C26H32O4 (408.23)


   

(1r,3r,3as,4s,5r,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1r,3r,3as,4s,5r,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)